Clinical trial Recruiting at 1 site Observational Ages 6 Months to 99

Observing how congenital myasthenic syndromes affect patients over time

Official title: A Single Center Prospective Natural History and Outcome Measure Validation Study of Congenital Myasthenic Syndromes

Run by National Institutes of Health Clinical Center (CC) · NCT06630650 · Data updated 2026-11-12

This study is tracking how congenital myasthenic syndromes affect people over five years to better understand the condition and help improve future treatments.

Quick facts

Study typeObservational
Ages6 Months to 99 Years
SexAll
Enrollment75 (estimated)
SponsorNational Institutes of Health Clinical Center (CC)
NIH
Locations1 site (Bethesda, Maryland)
StatusRecruiting
StartedMay 12, 2025
Main results expectedDecember 2, 2042
Study endsDecember 2, 2044
Registry record updatedAugust 13, 2026
Trial IDNCT06630650 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals aged six months or older with genetically confirmed congenital myasthenic syndromes.

Probably not a fit

Patients without a confirmed genetic diagnosis of congenital myasthenic syndromes may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to understand the natural history of congenital myasthenic syndromes (CMS) by following participants over a five-year period. Individuals aged six months and older with genetically confirmed CMS will undergo a series of tests, including physical exams, heart and lung function assessments, and muscle ultrasounds. The study focuses on DOK7 and COLQ-related CMSs, aiming to characterize clinical manifestations and validate outcome measures for future clinical trials. Participants will have up to seven visits, allowing researchers to track changes in physical strength, performance, and disease severity.

Why it matters

Potential benefit: If successful, this study could lead to improved understanding and management of congenital myasthenic syndromes, enhancing patient care.

How similar studies have gone: While studies on congenital myasthenic syndromes are limited, similar observational studies have provided valuable insights into rare neuromuscular disorders.

Who can join: the full rules

Show full inclusion / exclusion criteria
* INCLUSION CRITERIA:

In order to be eligible to participate in this study, an individual must meet all of the following criteria:

* Stated willingness to comply with all study procedures and availability for the duration of the study
* Male or female, aged \>= 6 months of age
* Clinically stable as evidenced by medical record review and remote screening questionnaire
* Genetically confirmed congenital myasthenic syndrome (pathogenic or likely pathogenic variants identified by CLIA testing in an established CMS-related gene including but not limited to DOK7, COLQ, CHRNE, RAPSN, CHAT, GFPT1, DPAGT1 OR pathogenic/likely pathogenic variant in combination with a variant of uncertain significance (VUS) AND additional clinical supporting evidence of CMS).
* Agreement to adhere to Lifestyle Considerations throughout study duration
* Ability of subject to understand and the willingness to provide informed consent (\>=18 years of age) and assent (\>=7 years of age).

EXCLUSION CRITERIA:

* Received gene transfer therapy
* Pregnant women (prior to enrollment)
* Ongoing medical condition or medication use that is deemed by the Principal Investigator to interfere with the conduct or assessments of the study or safety of the subject.

Where it's running

  • National Institutes of Health Clinical Center
    Bethesda, Maryland, United States
    Recruiting

Study contacts

  • Principal investigator: Christopher Grunseich, M.D. — National Institute of Neurological Disorders and Stroke (NINDS)
  • Study coordinator: Dana L Macdonald
  • Email: dana.macdonald@nih.gov
  • Phone: (301) 594-1090

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.